{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:21:29Z","timestamp":1793683289499,"version":"4.5.1"},"reference-count":76,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"unspecified","delay-in-days":263,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2024,8,12]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The aim of this systematic review and meta-analysis is to evaluate and compare the prevalence rates of spontaneous movement disorders (SMDs), including dyskinesia, parkinsonism, akathisia and dystonia, in antipsychotic-na\u00efve individuals with chronic psychosis and first-episode psychosis (FEP) and gain a more nuanced understanding of factors influencing their presence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Several literature databases were systematically searched and screened based on predetermined eligibility criteria. Included articles underwent risk of bias assessment. The prevalence rates of SMDs were calculated using a random-effects model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 711 articles screened, 27 were included in this meta-analysis. The pooled prevalence of spontaneous dyskinesia was 7% (3% FEP and 17% chronic schizophrenia) across 24 studies (95% CI 3 to 11; I<jats:sup>2<\/jats:sup>=94%, p&lt;0.01) and 15% for spontaneous parkinsonism (14% FEP and 19% chronic schizophrenia) in 21 studies (95% CI 12 to 20; I<jats:sup>2<\/jats:sup>=81%, p&lt;0.01). A meta-regression analysis found a significant positive correlation between age (p&lt;0.05) and duration of untreated psychosis (DUP) (p&lt;0.05) with dyskinesia but not parkinsonism prevalence. Akathisia and dystonia appear to be both less studied and less frequent in occurrence with a pooled prevalence of 4% (95% CI: 3 to 6; I<jats:sup>2<\/jats:sup>=0%, p=0.65) for akathisia in eight studies and a mean prevalence of 6% (range 0%\u201316%) for dystonia in five studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The presence of varying degrees of neurodysfunction in antipsychotic-na\u00efve patients with schizophrenia underscores the need for individualised treatment approaches that consider each patient\u2019s unique predisposition and neuromotor profile. Further research is warranted into the role of specific SMDs and risk factors including sex, race and diagnostic variations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42024501951.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjment-2024-301184","type":"journal-article","created":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T23:15:16Z","timestamp":1727046916000},"page":"e301184","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1002-6194","authenticated-orcid":false,"given":"Arturas","family":"Kalniunas","sequence":"first","affiliation":[{"name":"Research and Development, West London NHS Trust, London, UK"},{"name":"Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"James","sequence":"additional","affiliation":[{"name":"Addiction Services, Central and North West London Mental Health NHS Trust, London, Greater London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Pappa","sequence":"additional","affiliation":[{"name":"Research and Development, West London NHS Trust, London, UK"},{"name":"Department of Psychiatry, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,9,22]]},"reference":[{"key":"2025082700233556000_27.1.e301184.1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41398-020-0796-8","article-title":"On the diagnostic and neurobiological origins of bipolar disorder","volume":"10","author":"Charney","year":"2020","journal-title":"Transl Psychiatry"},{"key":"2025082700233556000_27.1.e301184.2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/mp.2014.66","article-title":"The neurobiology and treatment of first-episode schizophrenia","volume":"20","author":"Kahn","year":"2015","journal-title":"Mol Psychiatry"},{"key":"2025082700233556000_27.1.e301184.3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18111271"},{"key":"2025082700233556000_27.1.e301184.4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","article-title":"Schizophrenia, Dopamine and the Striatum: from Biology to Symptoms","volume":"42","author":"McCutcheon","year":"2019","journal-title":"Trends Neurosci"},{"key":"2025082700233556000_27.1.e301184.5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213880120","article-title":"Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium","volume":"120","author":"Schijven","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082700233556000_27.1.e301184.6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pscychresns.2006.10.002","article-title":"Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug","volume":"154","author":"Glenthoj","year":"2007","journal-title":"Psychiatr Res Neuroimaging"},{"key":"2025082700233556000_27.1.e301184.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.06.008"},{"key":"2025082700233556000_27.1.e301184.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.196"},{"key":"2025082700233556000_27.1.e301184.9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/1570159X14666161208153644","article-title":"Revisiting Antipsychotic-induced Akathisia: current Issues and Prospective Challenges","volume":"15","author":"Salem","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"2025082700233556000_27.1.e301184.10","unstructured":"Bleuler E . Dementia praecox or the group of schizophrenia. New York, NY: International University Press, 1950."},{"key":"2025082700233556000_27.1.e301184.11","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291708004716"},{"key":"2025082700233556000_27.1.e301184.12","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.116.4.796"},{"key":"2025082700233556000_27.1.e301184.13","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.116.2.260"},{"key":"2025082700233556000_27.1.e301184.14","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn146"},{"key":"2025082700233556000_27.1.e301184.15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0000000000000666","article-title":"High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders","volume":"37","author":"Mentzel","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"2025082700233556000_27.1.e301184.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025588","article-title":"Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder","volume":"6","author":"Bakker","year":"2011","journal-title":"PLoS ONE"},{"key":"2025082700233556000_27.1.e301184.17","first-page":"314","article-title":"Ethnicity and movement disorders","volume":"63","author":"Eastham","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"2025082700233556000_27.1.e301184.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0294-x"},{"key":"2025082700233556000_27.1.e301184.19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41380-020-0660-5","article-title":"The genetics of drug-related movement disorders, an umbrella review of meta-analyses","volume":"25","author":"van der Burg","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2025082700233556000_27.1.e301184.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025082700233556000_27.1.e301184.21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int J Health Policy Manag"},{"key":"2025082700233556000_27.1.e301184.22","unstructured":"Tufanaru C , Munn Z , Aromataris E , et al . JBI manual for evidence synthesis - jbi manual for evidence synthesis- jbi global wiki. 2020. Available: https:\/\/synthesismanual.jbi.global"},{"key":"2025082700233556000_27.1.e301184.23","unstructured":"TIJ B . Joanna Briggs Institute reviewers\u2019 manual. 2nd edn. Adelaide: The Joanna Briggs Institute, 2014."},{"key":"2025082700233556000_27.1.e301184.24","unstructured":"Dunnigan K . Confidence interval calculation for binomial proportions introduction: background -confidence interval calculation. 2008. Available: https:\/\/www.mwsug.org\/proceedings\/2008\/pharma\/MWSUG-2008-P08.pdf"},{"key":"2025082700233556000_27.1.e301184.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025082700233556000_27.1.e301184.26","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2013-203104"},{"key":"2025082700233556000_27.1.e301184.27","doi-asserted-by":"publisher","DOI":"10.3102\/10769986030003261"},{"key":"2025082700233556000_27.1.e301184.28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7140"},{"key":"2025082700233556000_27.1.e301184.29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"key":"2025082700233556000_27.1.e301184.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.6.676"},{"key":"2025082700233556000_27.1.e301184.31","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.11"},{"key":"2025082700233556000_27.1.e301184.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1221"},{"key":"2025082700233556000_27.1.e301184.33","unstructured":"Borenstein M , Hedges LV , Higgins JPT , et al . Introduction to Meta-Analysis. New York, NY: John Wiley & Sons, 2011."},{"key":"2025082700233556000_27.1.e301184.34","unstructured":"Raudenbush SW . Analyzing Effect Sizes: Random-Effects Models. 2nd edn. New York, United States: Russell Sage Foundation, 2009:295\u2013315."},{"key":"2025082700233556000_27.1.e301184.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2025082700233556000_27.1.e301184.36","doi-asserted-by":"publisher","DOI":"10.1080\/13651500500329150"},{"key":"2025082700233556000_27.1.e301184.37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12888-014-0280-1","article-title":"Movement disorders in neuroleptic-na\u00efve patients with schizophrenia spectrum disorders","volume":"14","author":"Ayehu","year":"2014","journal-title":"BMC Psychiatry"},{"key":"2025082700233556000_27.1.e301184.38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5958\/2394-2061.2017.00005.2","article-title":"Prevalence of spontaneous dyskinesia in first episode, drug naive schizophrenia, and its relation to the positive and negative symptoms of schizophrenia","volume":"8","author":"Bhandari","year":"2017","journal-title":"Open J Psychiatry Allied Sci"},{"key":"2025082700233556000_27.1.e301184.39","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)91199-1"},{"key":"2025082700233556000_27.1.e301184.40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/jnp.9.4.562","article-title":"Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients","volume":"9","author":"Caligiuri","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025082700233556000_27.1.e301184.41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaac.2015.06.015","article-title":"Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics","volume":"54","author":"Carbon","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2025082700233556000_27.1.e301184.42","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.12.1724"},{"key":"2025082700233556000_27.1.e301184.43","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505000707"},{"key":"2025082700233556000_27.1.e301184.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.08.003"},{"key":"2025082700233556000_27.1.e301184.45","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbt125"},{"key":"2025082700233556000_27.1.e301184.46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00004714-198210000-00017","article-title":"Spontaneous involuntary disorders of movement","volume":"2","author":"Cunningham Owens","year":"1982","journal-title":"J Clin Psychopharmacol"},{"key":"2025082700233556000_27.1.e301184.47","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.9.1202"},{"key":"2025082700233556000_27.1.e301184.48","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105051539"},{"key":"2025082700233556000_27.1.e301184.49","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s11434-011-4738-y","article-title":"First episode psychosis with extrapyramidal signs prior to antipsychotic drug treatment","volume":"56","author":"Honer","year":"2011","journal-title":"Chin Sci Bull"},{"key":"2025082700233556000_27.1.e301184.50","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246179"},{"key":"2025082700233556000_27.1.e301184.51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1665.2000.00237.x"},{"key":"2025082700233556000_27.1.e301184.52","first-page":"S19","article-title":"Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs","volume":"2","author":"Kopala","year":"1998","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2025082700233556000_27.1.e301184.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.09.009"},{"key":"2025082700233556000_27.1.e301184.54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/JCP.0b013e3181845f59","article-title":"Spontaneous dyskinesia in first-episode psychosis in a Southeast Asian population","volume":"28","author":"Lee","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"2025082700233556000_27.1.e301184.55","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.2.184"},{"key":"2025082700233556000_27.1.e301184.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2004.08.002"},{"key":"2025082700233556000_27.1.e301184.57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fpsyt.2018.00172","article-title":"Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia","volume":"9","author":"Ojagbemi","year":"2018","journal-title":"Front Psychiatry"},{"key":"2025082700233556000_27.1.e301184.58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/09638237.2020.1739242","article-title":"Spontaneous and emergent extrapyramidal syndromes in Black Africans with first-episode schizophrenia and first exposure to antipsychotics","volume":"30","author":"Ojagbemi","year":"2021","journal-title":"J Ment Health"},{"key":"2025082700233556000_27.1.e301184.59","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23050"},{"key":"2025082700233556000_27.1.e301184.60","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs152"},{"key":"2025082700233556000_27.1.e301184.61","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.1.76"},{"key":"2025082700233556000_27.1.e301184.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.07.001"},{"key":"2025082700233556000_27.1.e301184.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.02.013"},{"key":"2025082700233556000_27.1.e301184.64","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290040080012"},{"key":"2025082700233556000_27.1.e301184.65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03366.x"},{"key":"2025082700233556000_27.1.e301184.66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS","volume":"45","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"2025082700233556000_27.1.e301184.67","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.3.323"},{"key":"2025082700233556000_27.1.e301184.68","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"2025082700233556000_27.1.e301184.69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"2025082700233556000_27.1.e301184.70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257129","article-title":"Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies","volume":"16","author":"Ali","year":"2021","journal-title":"PLoS ONE"},{"key":"2025082700233556000_27.1.e301184.71","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-152"},{"key":"2025082700233556000_27.1.e301184.72","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.9.4.426"},{"key":"2025082700233556000_27.1.e301184.73","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1017\/S0033291723003458","article-title":"What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies","volume":"54","author":"Salazar de Pablo","year":"2024","journal-title":"Psychol Med"},{"key":"2025082700233556000_27.1.e301184.74","unstructured":"Borenstein M . Common Mistakes in Meta-Analysis and How to Avoid Them. Englewood, NJ: Biostat. Inc, 2009."},{"key":"2025082700233556000_27.1.e301184.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.006"},{"key":"2025082700233556000_27.1.e301184.76","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950080055008"}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2024-301184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:23:47Z","timestamp":1756279427000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2024-301184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,22]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/bmjment-2024-301184"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2024-301184","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}